Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)

Clinical trial NCT06005818 · RECRUITING

Trial details

NCT number: NCT06005818
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2024-01-01
Primary completion: 2027-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.